Russell Investments Group, Ltd. Assembly Biosciences, Inc. Transaction History

Russell Investments Group, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$1.46 - $2.45 $180,672 - $303,182	-123,748 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$2.13 - $3.46 $76,918 - $124,947	36,112 Added 41.21%	123,748 $288,000
Q3 2021 Nov 08, 2021	BUY	$3.14 - $3.9 $115,878 - $143,925	36,904 Added 72.74%	87,636 $304,000
Q2 2021 Aug 04, 2021	SELL	$3.8 - $4.56 $310,194 - $372,232	-81,630 Reduced 61.67%	50,732 $195,000
Q1 2021 May 10, 2021	BUY	$4.33 - $6.63 $566,186 - $866,932	130,759 Added 8157.14%	132,362 $607,000
Q4 2020 Feb 08, 2021	SELL	$4.87 - $17.29 $83,496 - $296,437	-17,145 Reduced 91.45%	1,603 $9,000
Q4 2019 Jan 29, 2020	SELL	$8.36 - $23.81 $332,184 - $946,090	-39,735 Reduced 67.94%	18,748 $382,000
Q3 2019 Nov 01, 2019	BUY	$9.83 - $14.82 $574,887 - $866,718	58,483 New	58,483 $576,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $765M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.